Comparison of Diagnostic Efficiency Between IOTA LR2 Model and Doctors Experiences

Overview

Journal Zhong Nan Da Xue Xue Bao Yi Xue Ban

Specialty General Medicine

Date 2022 Sep 13

PMID 36097776

Authors

Baihua Zhao

Yaqian Fu

Lieming Wen

Zhiyuan Wang

Chun Fu

Minghui Liu

Affiliations

Soon will be listed here.

Abstract

Objectives: International Ovarian Tumor Analysis (IOTA) working group proposed a logistic regression (IOTA LR2) model. It is served as a risk prediction model for benign and malignant adnexal tumors. This study aims to compare the diagnostic efficiency between the IOTA LR2 model and doctors' subjective assessment on diagnosing benign and malignant adnexal mass.

Methods: The ultrasonographic images of 616 adnexal masses were retrospectively analyzed by the senior doctors' group and the junior doctors' group using the IOTA LR2 model and subjective assessment. The postoperative pathological diagnosis was used as the gold standard to compare the diagnostic efficiency of the 2 methods.

Results: The area under the curves of subjective assessment and IOTA LR2 model for diagnosing malignant adnexal masses were 0.86 and 0.90 for the senior doctors' group and 0.79 and 0.88 for the junior doctors' group, respectively. The sensitivity and specificity of subjective assessment for diagnosing the malignant adnexal masses were 81.0% and 91.3% for the senior doctors' group and 70.1% and 88.7% for the junior doctors' group, respectively. The sensitivity and specificity of the IOTA LR2 model for diagnosing the malignant adnexal masses were 79.6% and 88.1% for the senior doctors' group, and 79.6% and 81.7% for the junior doctors' group, respectively.There were no significant difference in the sensitivities between the senior doctors' group and junior doctors' group using the IOTA LR2 model and the senior doctors' group using subjective assessment (both >0.05).

Conclusions: The diagnostic efficiency of the IOTA LR2 model is equal to the senior doctors' experiences. This model can help junior doctors to reduce the missed diagnosis of malignant adnexal masses.

Citing Articles

Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.

Tian C, Wen S, Zhao C, Yan X, Du J BMC Womens Health. 2023; 23(1):585.

PMID: 37940895 PMC: 10633950. DOI: 10.1186/s12905-023-02719-z.

References

Guo Y, Zhao B, Zhou S, Wen L, Liu J, Fu Y . A comparison of the diagnostic performance of the O-RADS, RMI4, IOTA LR2, and IOTA SR systems by senior and junior doctors. Ultrasonography. 2022; 41(3):511-518. PMC: 9262660. DOI: 10.14366/usg.21237. View

Baker V . Treatment options for ovarian cancer. Clin Obstet Gynecol. 2001; 44(3):522-30. DOI: 10.1097/00003081-200109000-00007. View

Koneczny J, Czekierdowski A, Florczak M, Poziemski P, Stachowicz N, Borowski D . The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses. Ginekol Pol. 2018; 88(12):647-653. DOI: 10.5603/GP.a2017.0116. View

Nunes N, Ambler G, Foo X, Widschwendter M, Jurkovic D . Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting. Ultrasound Obstet Gynecol. 2017; 51(6):829-835. DOI: 10.1002/uog.18918. View

Hidalgo J, Llueca A, Zolfaroli I, Veiga N, Ortiz E, Alcazar J . Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses. Med Ultrason. 2021; 23(2):168-175. DOI: 10.11152/mu-2732. View

Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I . Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound Obstet Gynecol. 2012; 41(1):9-20. DOI: 10.1002/uog.12323. View

Nunes N, Yazbek J, Ambler G, Hoo W, Naftalin J, Jurkovic D . Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2012; 40(3):355-9. DOI: 10.1002/uog.11088. View

Timmerman D . The use of mathematical models to evaluate pelvic masses; can they beat an expert operator?. Best Pract Res Clin Obstet Gynaecol. 2004; 18(1):91-104. DOI: 10.1016/j.bpobgyn.2003.09.009. View

Abramowicz J, Timmerman D . Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules. Am J Obstet Gynecol. 2017; 217(6):652-660. DOI: 10.1016/j.ajog.2017.07.019. View

10.

Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas J . A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990; 97(10):922-9. DOI: 10.1111/j.1471-0528.1990.tb02448.x. View

11.

Timmerman D, Valentin L, Bourne T, COLLINS W, Verrelst H, Vergote I . Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol. 2001; 16(5):500-5. DOI: 10.1046/j.1469-0705.2000.00287.x. View

12.

Kossai M, Leary A, Scoazec J, Genestie C . Ovarian Cancer: A Heterogeneous Disease. Pathobiology. 2017; 85(1-2):41-49. DOI: 10.1159/000479006. View

13.

Amor F, Alcazar J, Vaccaro H, Leon M, Iturra A . GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study. Ultrasound Obstet Gynecol. 2011; 38(4):450-5. DOI: 10.1002/uog.9012. View

14.

Timmerman D, Testa A, Bourne T, Ferrazzi E, Ameye L, Konstantinovic M . Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005; 23(34):8794-801. DOI: 10.1200/JCO.2005.01.7632. View